(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.59%) $83.22
(0.11%) $1.759
(0.17%) $2 402.10
(1.15%) $28.71
(-1.25%) $942.60
(-0.08%) $0.939
(-0.18%) $11.02
(0.53%) $0.808
(-0.94%) $93.02
Live Chart Being Loaded With Signals
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders...
Stats | |
---|---|
Today's Volume | 71 300.00 |
Average Volume | 572 391 |
Market Cap | 5.36M |
EPS | $0 ( 2023-08-04 ) |
Next earnings date | ( $0 ) 2024-05-03 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.270 |
ATR14 | $0.00200 (1.51%) |
Volume Correlation
NLS Pharmaceutics AG Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NLS Pharmaceutics AG Correlation - Currency/Commodity
NLS Pharmaceutics AG Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $-11 408.00 (0.00 %) |
EPS: | $-0.840 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-5 704.00 (0.00 %) |
EPS: | $-0.200 |
Q4 | 2022 |
Revenue: | $0 |
Gross Profit: | $-5 704.00 (0.00 %) |
EPS: | $-0.290 |
Q2 | 2022 |
Revenue: | $0 |
Gross Profit: | $-5 704.00 (0.00 %) |
EPS: | $-0.540 |
Financial Reports:
No articles found.
NLS Pharmaceutics AG
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators